Skip to main content
    N

    NeoGenomics Inc (NEO)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $16.84
    +0.35 (+2.12%)

    Market Cap: $2.13B

    Last updated: Nov 06, 2026 at 4:10 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    85%(34/40)
    Avg Surprise
    -20.96%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.11
    Range$0.09 - $0.13
    10 analysts
    Revenue Consensus
    $219M
    Range$218M - $220M
    8 analysts
    Period ending Mar 31, 2027
    EPS Consensus$0.06
    Range$0.00 - $0.09
    9 analysts
    EPS Revisions
    2
    0
    7d
    2
    5
    30d
    EPS Estimate DriftChange to current
    90d ago$0.06-3.9%
    60d ago$0.06-3.9%
    30d ago$0.06-3.9%
    7d ago$0.06+2.0%
    Current$0.06
    Revenue Consensus
    $207M
    Range$204M - $209M
    6 analysts
    Last 12 of 40 reported quarters and 2 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Mar 27EST
    		-$0.06$0.00 - $0.09--9
    2
    5
    30d
    		-
    Dec 26EST
    		-$0.11$0.09 - $0.13--10--
    Sep 26
    Reported Oct 28
    		$0.01$-0.01-+200.00%Beat11
    2
    1
    30d
    		-66.7%
    Jun 26
    Reported Jul 28
    		$-0.01N/A-+83.33%Beat11
    0
    1
    30d
    		-133.3%
    Mar 26
    Reported Apr 28
    		$0.01$0.01$-0.03 - $0.02-12.28%Miss9
    1
    5
    30d
    		+104.9%
    Dec 25
    Reported Feb 17
    		$0.06$0.04$0.01 - $0.06+50.00%Beat12
    1
    0
    30d
    		+50.0%
    Sep 25
    Reported Oct 28
    		$0.03$0.02$0.01 - $0.05+50.00%Beat13
    0
    12
    30d
    		+121.5%
    Jun 25
    Reported Jul 29
    		$0.03$0.02$0.01 - $0.06+50.00%Beat13
    0
    2
    30d
    		+0.0%
    Mar 25
    Reported Apr 29
    		$-0.20$-0.01$-0.02 - $0.03-1935.00%Miss12
    0
    1
    30d
    		-917.5%
    Dec 24
    Reported Feb 18
    		$0.04$0.03$0.01 - $0.07+39.86%Beat14
    1
    0
    30d
    		+33.3%
    Sep 24
    Reported Nov 5
    		$-0.14$0.01$-0.03 - $0.05-1494.00%Miss14
    1
    0
    30d
    		-597.0%
    Jun 24
    Reported Jul 29
    		$0.03$-0.00$-0.03 - $0.02+1404.35%Beat13
    No revisions (30d)
    		+160.0%
    Mar 24
    Reported Apr 30
    		$-0.02N/A-+60.00%Beat11
    No revisions (30d)
    		+77.8%
    Dec 23
    Reported Feb 20
    		$0.03$-0.03$-0.10 - $0.00+200.00%Beat13
    1
    0
    30d
    		+150.0%

    Dividends

    Last ex-dividend: Dec 17, 2020

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%
    FrequencySpecial
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio240.57EV/EBITDA74.58x
    Price/FCF-75.76xFCF Yield-1.32%
    Profitability
    Profit Margin-4.10%Operating Margin-3.78%
    ROE-3.94%ROIC-2.49%
    Financial Health
    Debt/Equity0.48xInterest Coverage-10.15x
    Current Ratio3.53xQuick Ratio3.31x
    Trading Statistics
    Beta1.83Avg Volume1.88M
    52-Week High$20.1552-Week Low$7.07

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$17.11
    SMA 20$16.89
    SMA 50$17.64
    SMA 200$12.88
    EMA 10$16.94
    EMA 20$17.05
    EMA 50$17.00
    EMA 200$14.00

    MACD

    Line: -0.15Signal: -0.15Hist: 0.01

    ADX

    ADX: 16.1+DI: 13.7-DI: 21.0

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down16.0
    PSAR$15.72

    Bollinger Bands

    Upper Band$17.86
    Lower Band$15.92
    %B Position1150%(Upper)
    Band Width0.48

    RSI (14-Day)

    Neutral
    47.7

    Momentum Oscillators

    Stoch %K40.0
    Stoch %D38.2
    Williams %R-58.2
    ROC (10d)1.5%
    Momentum0.25
    CCI (20d)-51.9
    MFI (14d)47.1

    Volatility Measures

    ATR (14d)$0.92(5.5%)
    StdDev (20d)0.49
    Hist Vol43.9%(High)

    Volume Flow

    VWAP$16.63
    OBV103.4M
    AD Line21.0M
    CMF (20d)0.121

    Volume Metrics

    Avg Vol (20d)1.8M
    Vol Ratio0.7x
    VWMA (20d)$16.97

    Pivot Points

    R3$17.96
    R2$17.43
    R1$16.96
    Pivot Point$16.43
    S1$15.96
    S2$15.43
    S3$14.96

    Advanced Oscillators

    TSI-4.67
    Ultimate Osc50.9
    KST-35.93

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$209.25M$201.66M$186.67M$190.17M$187.80M$181.33M$168.03M$172.00M$167.82M$164.50M$156.24M$155.55M
    Cost of Revenue$112.67M$109.78M$105.81M$114.46M$107.35M$104.07M$94.79M$94.74M$92.94M$92.01M$90.77M$87.96M
    Gross Profit$96.59M$91.88M$80.86M$75.71M$80.45M$77.26M$73.25M$77.26M$74.88M$72.49M$65.47M$67.59M
    Operating Expenses$104.53M$101.65M$99.11M$86.85M$107.46M$124.89M$101.07M$95.66M$96.08M$94.44M$96.04M$86.16M
    R&D$9.86M$10.76M$9.53M$9.18M$8.69M$9.02M$10.18M$7.97M$7.68M$7.89M$7.62M$7.13M
    SG&A$67.07M$63.61M$65.74M$63.51M$69.87M$71.75M$65.22M$63.64M$66.97M$63.33M$65.80M$59.76M
    Operating Income$-7,941,000$-9,771,000$-18,241,000$-11,141,000$-27,014,000$-47,628,000$-27,825,000$-18,401,000$-21,197,000$-21,941,000$-30,567,000$-18,574,000
    Interest Income$1.20M$1.21M$1.27M$1.52M$1.56M$2.26M$3.72M$4.33M$4.67M$4.59M$4.83M$10.07M
    Interest Expense$1.27M$781,000$598,000$599,000$603,000$933,000$1.62M$1.62M$1.64M$1.67M$1.69M$1.68M
    Income Before Tax$-8,021,000$1.83M$-17,578,000$-12,406,000$-26,389,000$-45,816,000$-25,657,000$-16,128,000$-17,849,000$-19,017,000$-27,681,000$-15,286,000
    Income Tax Expense$-475,000$-412,000$-472,000$-2,525,000$740,000$-724,000$266,000$-804,000$-150,000$-375,000$-620,000$-960,000
    Net Income$-7,546,000$2.24M$-17,106,000$-9,881,000$-27,129,000$-45,092,000$-25,923,000$-15,324,000$-17,699,000$-18,642,000$-27,061,000$-14,326,000
    EBITDA$9.44M$18.82M$-567,000$4.59M$-9,952,000$-27,619,000$-6,311,000$3.68M$1.78M$756,000$-7,729,000$4.76M
    EBIT$-6,754,000$2.61M$-16,980,000$-11,807,000$-26,389,000$-44,883,000$-24,039,000$-14,504,000$-16,207,000$-17,351,000$-25,996,000$-13,605,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NEO

    Government Contracts

    Gov Obligations (TTM)
    $2.60M
    Gov Obligations / Revenue
    0.3%
    Obligations YoY
    5.2%
    Active Awards
    17
    New Awards (TTM)
    8
    Avg Remaining Term
    6.2 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C25726N0072Department of Veterans AffairsDepartment of Veterans Affairs$2.79MJan 1, 2026
    36C26126N0417Department of Veterans AffairsDepartment of Veterans Affairs$643694Apr 26, 2026
    36C24126N0285Department of Veterans AffairsDepartment of Veterans Affairs$500000Apr 1, 2026
    36C25726N0390Department of Veterans AffairsDepartment of Veterans Affairs$493650Jul 1, 2026
    75H71226F28001Department of Health and Human ServicesIndian Health Service$401779Jun 1, 2026
    36C26126N0169Department of Veterans AffairsDepartment of Veterans Affairs$325000Oct 26, 2025
    36C25926N0228Department of Veterans AffairsDepartment of Veterans Affairs$100000Jul 1, 2026
    36C24826N0008Department of Veterans AffairsDepartment of Veterans Affairs$10000Oct 1, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    NEO Valuation and Fair Value

    P/E
    240.6x
    Forward P/E
    222.2x
    EV/EBITDA
    74.6x
    P/FCF
    -75.8x
    PEG
    2.1x
    P/B
    2.7x
    See GNG's fair value

    NEO Profitability: Margins, ROIC and FCF

    Gross margin
    43.8%
    Operating margin
    -3.8%
    Net margin
    -4.1%
    ROIC
    -2.5%
    ROE
    -3.9%
    FCF margin
    -3.6%
    FCF yield
    -1.3%

    NEO Competitors

    CompanyTicker
    Schrodinger IncSDGR
    Dynavax Technologies CorporationDVAX
    Vera Therapeutics IncVERA
    BioCryst Pharmaceuticals IncBCRX
    Perrigo Company PLCPRGO
    Biohaven Ltd.BHVN
    Recursion Pharmaceuticals IncRXRX
    Prestige Brand Holdings IncPBH

    Sector: Healthcare

    NEO Analyst Ratings

    Consensus
    Buy
    Analysts
    12
    Strong Buy
    2
    Buy
    6
    Hold
    4
    Sell
    0
    Strong Sell
    0

    NEO Bull Case vs Bear Case

    Bull case

    • NEO beat EPS estimates in 75.0% of its last 8 reported quarters.
    • NEO grew quarterly revenue 11.4% year over year.
    • 66.7% of NEO's analyst ratings are Buy or Strong Buy.

    Bear case

    • NEO trades at 240.6x trailing earnings.
    • NEO has a -4.1% net profit margin.

    NEO Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    -184.3%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.11

    NEO Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%

    NEO Earnings Date

    NEO reports Feb 15, 2027, after the close. The date is estimated.

    NEO Earnings Call

    The latest NEO earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    NEO ETF Holders

    GNG tracks 14 ETFs that hold NEO. The largest weights:

    1. abrdn Healthcare Investors (HQH), 0.59% of the fund
    2. First Trust Small Cap Growth AlphaDEX Fund (FYC), 0.59% of the fund
    3. iShares Core S&P Small-Cap ETF (IJR), 0.13% of the fund
    4. Vanguard Morningstar Small-Cap Growth ETF (VBK), 0.07% of the fund
    5. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.05% of the fund
    Open the ETF Stock Exposure tool for NEO

    See insider activity

    Frequently Asked Questions About NEO

    When does NEO report earnings?

    NeoGenomics Inc (NEO) is expected to report earnings on Feb 15, 2027.

    Does NEO pay dividends?

    NeoGenomics Inc (NEO) has a dividend payment track record. See the NEO dividend history page for its current payment status, TTM yield, and recorded payments.

    What is NEO's P/E ratio?

    NeoGenomics Inc has a price-to-earnings (P/E) ratio of 240.57.

    What is NEO's market cap?

    NeoGenomics Inc (NEO) has a market capitalization of $2.13B with a current stock price of $16.84.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In